About Implantica MediSwiss AG

Implantica MediSwiss is the major shareholder of Implantica AG, a company listed on the Nasdaq First North Premier Growth Market. Implantica is a medtech group dedicated to bringing innovative advances in technology into the body. Medical implants previously seen as unachievable will seek to alleviate unmet medical needs

Documents

Financials

_{Published 17.08.2021}

• 2021-H1 Interim Financial Statements Implantica MediSwiss AG
• 2020-12-31 Statutory Financial Statements Implantica MediSwiss AG
• 2019-12-31 Statutory Financial Statements Implantica MediSwiss AG
• 2018-12-31 Statutory Financial Statements Implantica MediSwiss AG

Merger

_{Published 17.08.2021}

• Expert Merger Report by Deloitte, Implantica AG and Implantica MediSwiss AG
• Merger Report, Implantica AG and Implantica MediSwiss AG
• Certified Merger plan, Implantica AG and Implantica MediSwiss AG

Extraordinary General Meeting 17 September 2021

_{Published 17.08.2021}

• Notice of Extraordinary General Meeting of Implantica AG
• Notification of participation and form for postal voting
• Certified Merger plan, Implantica AG and Implantica MediSwiss AG

Contact

Implantica Group

General queries

+41 41 539 19 02 / +423 376 60 66 info@implantica.com

Investor relations queries

investorrelations@implantica.com

Implantica Management AG

Implantica Trading AG

Baarerstrasse 57
CH-6300 Zug
Switzerland